SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003073
Filing Date
2022-11-09
Accepted
2022-11-09 16:27:56
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20220930x10q.htm   iXBRL 10-Q 1990327
2 EX-31._1 nwbo-20220930xex31d1.htm EX-31._1 10020
3 EX-32._1 nwbo-20220930xex32d1.htm EX-32._1 7123
  Complete submission text file 0001410578-22-003073.txt   8735653

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20220930.xsd EX-101.SCH 69103
5 EX-101.CAL nwbo-20220930_cal.xml EX-101.CAL 49242
6 EX-101.DEF nwbo-20220930_def.xml EX-101.DEF 293848
7 EX-101.LAB nwbo-20220930_lab.xml EX-101.LAB 453496
8 EX-101.PRE nwbo-20220930_pre.xml EX-101.PRE 392068
56 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20220930x10q_htm.xml XML 1780256
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 221373084
SIC: 2834 Pharmaceutical Preparations